skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Folate Receptor-Targeted Tubulysin Conjugate EC1456 (Code C113176)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Folate Receptor-Targeted Tubulysin Conjugate EC1456

Definition: An injectable targeted small molecule drug conjugate (SMDC) consisting of folate (vitamin B9) covalently linked to the potent mitotic poison and cytotoxic agent, tubulysin B hydrazide (Tub-B-H) with potential antineoplastic activity. Upon administration, the folate moiety of folate receptor-targeted tubulysin conjugate EC1456 preferentially binds to tumor cells expressing folate receptors (FR). After binding to FR, the agent is internalized by tumor cells and the Tub-B-H moiety inhibits the polymerization of tubulin into microtubules. This may lead to both cell cycle arrest and tumor cell apoptosis. FR, the membrane-bound, high-affinity receptor for folate, is overexpressed on a wide range of primary and metastatic human cancers.

Display Name: Folate Receptor-Targeted Tubulysin Conjugate EC1456

Label: Folate Receptor-Targeted Tubulysin Conjugate EC1456

NCI Thesaurus Code: C113176 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL455247  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Folate Receptor-Targeted Tubulysin Conjugate EC1456
Folate Receptor-Targeting Folate-Tubulysin Conjugate EC1456

External Source Codes: 
PDQ Closed Trial Search ID 755557
PDQ Open Trial Search ID 755557 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C113176
Contributing_Source CTRP
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom